
₹30,937.50 Original price was: ₹30,937.50.₹6,436.00Current price is: ₹6,436.00.
Ahabir 250mg Tablet by Arogya is designed for high-dose therapy, targeting disease progression efficiently while maintaining patient safety.
| Country of Origin | India |
|---|---|
| Manufacturer | HETERO HEALTHCARE LTD |
| Pack Size | 120 Tablet(s) In A Bottle |
| Product Name | AHABIR 250MG TAB |
| SKU | AROG-AHB250 |
| Salt Composition | ABIRATERONE ACETATE |
| Strength | 250mg |
Ahabir 250mg Tablet contains the active constituent abiraterone acetate. It is used in adult men to treat prostate cancer, which has spread to other parts of the body. It is usually given with steroid medication to lower the chances of side effects. When Ahabir 250mg Tablet is prescribed for an early stage of this disorder, it is used with testosterone lowering treatment. This medicine is not for use in women or children. Effective contraception must be taken throughout the treatment. This medicine contains lactose and sodium, inform your physician if you have lactose intolerance or are on a salt control diet.
Inform your physician if the patients have liver problems, high blood pressure, heart disorders, low blood potassium, diabetes, allergic conditions, or other diseases. Make sure to inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start the treatment with this medication. The most common side effects of this medication are fluid in feet or legs, high blood pressure, and diarrhea. A decrease in red blood cells and reduced sex drive may also occur with the intake of Ahabir 250mg Tablet. This medicine should not be taken with Ra-223, which is used to treat prostate cancer.
Treatment of prostate cancer
Side effects are unwanted symptoms caused by medical treatment. Although all medicines can cause side effects, not everyone will experience them.
Serious:
Common:
Q1. How to take an Ahabir 250mg Tablet?
Ahabir 250mg Tablet should be taken as prescribed by the doctor and it should be taken on an empty stomach. Food must be eaten at least 2 hours before taking the medication, and the patient is advised to eat 1 hour after consuming the medication.
Q2. Can Ahabir 250mg Tablet cure prostate cancer?
Ahabir 250mg Tablet does not cure prostate cancer and it is used to treat prostate cancer which has spread to other parts of the body. It is usually given with steroid medication to lower the chances of side effects. This medication is prescribed at an early stage of the disorder and it is used along with testosterone lowering treatment.
Q3. Can Ahabir 250mg Tablet worsen liver diseases?
Ahabir 250mg Tablet is not recommended for patients with severe liver conditions as it can worsen the situation. Inform the doctor if the patient has liver disorders before taking this medication.
Q4. How do Ahabir 250mg Tablet work?
Ahabir 250mg Tablet is an anticancer medication. It works by preventing production of androgen and thereby inhibiting an enzyme responsible for the production of androgen.
Q5. Is Ahabir 250mg Tablet a chemotherapy drug?
No, Ahabir 250mg Tablet is not a chemotherapy drug; it is a hormonal treatment used to treat prostate cancer. It prevents the production of testosterone, thereby reducing the growth of prostate cancer.
Q6. What are the side effects of Ahabir 250mg Tablet?
The common side effects of Ahabir 250mg Tablet are fluids in legs, low blood potassium levels, high blood pressure, urinary tract infection, irregular heartbeat, diarrhea, rashes, and indigestion.
Arogya’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Arogya. Our mission is to support, not replace, the doctor-patient relationship.


